Collegium Pharmaceutical, Inc. COLL Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s software and technology licenses, net?
- Collegium Pharmaceutical, Inc. (COLL) reported software and technology licenses, net of $16.06M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s software and technology licenses, net changed year-over-year?
- Collegium Pharmaceutical, Inc.'s software and technology licenses, net increased by 218.9% year-over-year, from $5.04M to $16.06M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s software and technology licenses, net has grown at a 177.4% compound annual growth rate (CAGR), from $123K to $20.19M.